SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-032778
Filing Date
2023-09-15
Accepted
2023-09-15 16:45:27
Documents
55
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 797397
2 ex31-1.htm EX-31.1 11018
3 ex31-2.htm EX-31.2 10940
4 ex32-1.htm EX-32.1 5946
5 ex32-2.htm EX-32.2 6159
  Complete submission text file 0001493152-23-032778.txt   3594711

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE mira-20230630.xsd EX-101.SCH 29273
7 XBRL CALCULATION FILE mira-20230630_cal.xml EX-101.CAL 37979
8 XBRL DEFINITION FILE mira-20230630_def.xml EX-101.DEF 112965
9 XBRL LABEL FILE mira-20230630_lab.xml EX-101.LAB 218767
10 XBRL PRESENTATION FILE mira-20230630_pre.xml EX-101.PRE 181466
49 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 457217
Mailing Address 324 SOUTH HYDE PARK AVENUE, SUITE 350 TAMPA FL 33606
Business Address 855 N WOLFE STREET #623-6 BALTIMORE MD 21205 813-369-5150
MIRA PHARMACEUTICALS, INC. (Filer) CIK: 0001904286 (see all company filings)

IRS No.: 853354547 | State of Incorp.: FL
Type: 10-Q | Act: 34 | File No.: 001-41765 | Film No.: 231259250
SIC: 2834 Pharmaceutical Preparations